| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Tenet Healthcare Corporation New
$265.27
-9.07 (-3.31%)
Market Cap
21.32 B
EPS
39.42
P/E Ratio
6.96 $
Value Trade
231.51 M
0.58 %
Week
4.4 %
1 Month
58.31 %
3 Month
14.4 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
94.12 K
52 Week Range
157.58 - 283.05
% held by Insiders
1.14 %
% held by Institutions
100.63 %
Enterprise Value
19.15 B
Total Shares
80.52 M
Short %
3.17 %
Float Shares
85.32 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in THC
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
THC Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-THC
Jul 23, 2026▲ +17.2%on this news· ran to +29% by day 3
Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
Tenet Healthcare Corporation announced its second quarter 2026 results, highlighting strong same-store revenue growth and effective expense management. CEO Saum Sutaria noted that these factors contributed to the company's outperformance against initial financial expectations. The company is also focusing on operational execution and investments to navigate industry dynamics.
Read more →-THC
Jun 22, 2026Tenet to Report Its Second Quarter 2026 Results on July 24
Tenet Healthcare Corporation (THC) is set to report its second quarter results for 2026 on July 24. This announcement is part of their regular financial reporting schedule. Investors and analysts will be keen to assess the company's performance during this period.
Read more →-THC
May 6, 2026Tenet to Participate in the BofA Securities Health Care Conference
Tenet Healthcare Corporation is set to present at the BofA Securities Health Care Conference on May 13, 2026. The presentation will begin at 6:00 p.m. Eastern Time and will be available via a live webcast. Tenet Healthcare is recognized for its extensive healthcare services, including surgical centers and hospitals.
Read more →-THC
Apr 30, 2026Tenet Reports Strong First Quarter 2026 Results
Tenet Healthcare Corporation reported strong financial results for Q1 2026, with net operating revenues of $5.368 billion and net income of $702 million, significantly up from the previous year. The company's Ambulatory and Hospital segments showed growth, although adjusted EBITDA saw a slight decline. Tenet's outlook for 2026 remains positive, projecting revenues between $21.5 billion and $22.3 billion.
Read more →-THC
Apr 30, 2026Tenet Reports Strong First Quarter 2026 Results Net income available to common shareholders in first quarter 2026 was $702 million, or $8.01 per diluted share Adjusted diluted earnings per share 1 increased 10.6% to $4.8
Tenet Healthcare Corporation reported strong financial results for the first quarter of 2026, with net income of $702 million and adjusted diluted earnings per share of $4.82, marking a substantial year-over-year growth. The company's Ambulatory Care segment also experienced positive performance, with adjusted EBITDA increasing by 6.1%. However, there were challenges in the hospital segment, including a decline in outpatient visits and a decrease in same-hospital revenue per adjusted admission due to unfavorable payer mix. Nevertheless, Tenet maintained strong cash flows and a positive outlook for the full year.
Read more →-THC
Feb 11, 2026▲ +17.3%on this news
Tenet Reports Strong Fourth Quarter and FY 2025 Results Provides 2026 Financial Outlook Net income available to common shareholders in fourth quarter 2025 was $371 million, or $4.22 per diluted share Adjusted diluted ear
Tenet Healthcare Corporation (THC) reported robust financial results for the fourth quarter of 2025, posting a net income of $371 million or $4.22 per diluted share, alongside a notable 36.6% increase in adjusted diluted earnings per share from the previous year. The company achieved a consolidated adjusted EBITDA of $1.183 billion, reflecting a 12.9% growth. For fiscal year 2026, Tenet projects an adjusted EBITDA range between $4.485 billion and $4.785 billion. While the company maintained strong revenue growth, it recorded a decline in annual net income, primarily due to significant prior year gains from hospital divestitures.
Read more →-THC
Feb 2, 2026Tenet Announces Accretive Transaction and Previews Strong 2025 Results Tenet completes transaction with CommonSpirit Health to resume full ownership of Conifer Health Solutions. DALLAS
Tenet Healthcare Corporation has completed a transaction with CommonSpirit Health to regain full ownership of Conifer Health Solutions. The deal involves payments totaling approximately $1.9 billion over the next three years, which is expected to enhance Tenet's earnings in 2026. Additionally, Tenet anticipates strong revenue growth and improved cash flow for the year ended December 31, 2025. This agreement allows Conifer to continue supporting CommonSpirit's operations while expanding its focus on technology and innovation in revenue cycle management.
Read more →-THC
Nov 3, 2025Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes DALLAS
Tenet Healthcare Corporation (NYSE THC) has announced the private placement of $1.5 billion in senior secured notes and $0.5 billion in senior notes, totaling $2.0 billion. The proceeds will be used to refinance existing debt, aiming to enhance financial stability. These notes will not be registered under the Securities Act, which may restrict the ability to sell them to U.S. persons. The company has outlined risks and uncertainties about its future performance in accompanying statements.
Read more →-THC
Oct 28, 2025▼ -5.3%on this news
Tenet Reports Strong Third Quarter 2025 Results Raises 2025 Financial Outlook Net income available to common shareholders in third quarter 2025 was $342 million, or $3.86 per diluted share Adjusted diluted earnings per s
Tenet Healthcare Corporation (THC) reported strong financial results for the third quarter of 2025, highlighting a net income of $342 million, a significant increase in adjusted diluted earnings per share, and a rise in consolidated adjusted EBITDA. The company raised its adjusted EBITDA outlook for the full year 2025, reflecting a commitment to operational growth and cash flow generation. Notably, while the Ambulatory Care segment thrived, the hospital operations faced challenges such as a decrease in admissions and increased pressure on emergency room visits.
Read more →-THC
Jul 22, 2025▼ -10.7%on this news
Tenet Reports Strong Second Quarter 2025 Results Raises 2025 Financial Outlook Net income available to common shareholders in second quarter 2025 was $288 million, or $3.14 per diluted share Adjusted diluted earnings per
Tenet Healthcare Corporation reported strong financial results for the second quarter of 2025, with net income available to shareholders increasing to $288 million. The company raised its financial outlook for the year, projecting adjusted EBITDA of up to $4.54 billion. Notably, adjusted diluted earnings per share surged by 74% compared to the previous year. Investments and a robust free cash flow were highlighted as key components of their ongoing strategy to enhance operational effectiveness.
Read more →-THC
Apr 29, 2025▲ +11.7%on this news
Tenet Reports Strong First Quarter 2025 Results Net income available to common shareholders in first quarter 2025 was $406 million, or $4.27 per diluted share Adjusted diluted earnings per share 1 increased 35.4% to $4.3
Tenet Healthcare Corporation reported robust first-quarter results for 2025, achieving a net income of $406 million or $4.27 per diluted share. Adjusted diluted earnings per share surged by 35.4% to $4.36, driven by operational efficiencies and strong revenue growth. The company experienced a consolidated Adjusted EBITDA increase of 13.6%, although net operating revenues declined slightly from the previous year. Management remains positive about future performance, anticipating continued growth in Adjusted EBITDA and revenues for the full fiscal year 2025.
Read more →-THC
Feb 12, 2025▼ -9.1%on this news
Tenet Reports Strong Fourth Quarter and FY 2024 Results Provides 2025 Financial Outlook Net income available to common shareholders in fourth quarter 2024 was $318 million, or $3.32 per diluted share Adjusted diluted ear
Tenet Healthcare Corporation reported strong financial results for the fourth quarter of 2024, highlighting a net income of $318 million and an Adjusted EBITDA of $1.048 billion. The company anticipates continued growth with a financial outlook for 2025 projecting Adjusted EBITDA between $3.975 billion and $4.175 billion. Despite a decline in net operating revenues resulting from hospital divestitures, Tenet's focus on efficient operations and high patient satisfaction levels contributed to their successful performance. Additionally, Tenet's strategic changes in operational management provided momentum for future expectations.
Read more →-THC
Oct 29, 2024▲ +16.7%on this news
Tenet Reports Strong Third Quarter 2024 Results Raises 2024 Financial Outlook Net income available to common shareholders in third quarter 2024 was $472 million, or $4.89 per diluted share, including an after-tax gain of
Tenet Healthcare Corporation reported strong financial results for the third quarter of 2024, with net income rising to $472 million, significantly above the previous year's figures. Adjusted EBITDA grew by 14.5%, supported by improved same-store revenue and profitability. The company increased its full-year Adjusted EBITDA outlook by $50 million to a range of $3.9 billion to $4.0 billion. Despite the positive performance overall, certain challenges were noted, including a decrease in net operating revenues for the hospital segment linked to previously executed divestitures.
Read more →-THC
Aug 5, 2024Tenet Healthcare to Sell Five Birmingham Hospitals to Orlando Health Tenet announces agreement to sell Birmingham hospitals and related operations reaffirms latest FY24 Adjusted EBITDA Outlook DALLAS
Tenet Healthcare Corporation has entered into a definitive agreement with Orlando Health to sell its 70% majority interest in Brookwood Baptist Health, which includes five hospitals in Birmingham, for approximately $910 million. The deal is expected to yield a pre-tax book gain of about $375 million and will be completed in fall 2024, pending regulatory approvals. Additionally, Tenet's Conifer Health Solutions subsidiary will secure a new ten-year contract to manage revenue cycle services for the sold facilities. The agreement positions Orlando Health to enhance its healthcare services in the Birmingham area.
Read more →-THC
Jul 24, 2024Tenet Reports Strong Second Quarter 2024 Results Raises 2024 Financial Outlook Net income available to common shareholders in second quarter 2024 was $259 million, or $2.64 per diluted share Adjusted diluted earnings per
Tenet Healthcare Corporation reported strong financial results for the second quarter of 2024, with a net income of $259 million, reflecting substantial growth from the previous year. The company also announced a new $1.5 billion share repurchase program and raised its Adjusted EBITDA outlook for the year, highlighting solid operating performance and volume growth. However, the Hospital segment experienced a 4.3% decline in net operating revenues, attributed to recent divestitures. Overall, the outlook for the remainder of 2024 remains optimistic despite some challenges in specific segments.
Read more →-THC
Apr 30, 2024▲ +13.3%on this news
Tenet Reports First Quarter 2024 Results Well in Excess of Guidance Raises 2024 Financial Outlook Net income from continuing operations available to common shareholders in first quarter 2024 was $2.151 billion, or $21.38
Tenet Healthcare Corporation reported robust financial results for Q1 2024, achieving net income of $2.151 billion, significantly higher than the previous year's $143 million. The company has raised its full-year 2024 outlook for Adjusted EBITDA to a range of $3.5 billion to $3.7 billion, reflecting strong growth in revenues and profitability. The results were bolstered by a substantial after-tax gain from hospital divestitures and effective operational management, including improvements in admission rates and contract labor costs.
Read more →-THC
Apr 1, 2024Tenet Completes Sale of Six Hospitals in California DALLAS
Tenet Healthcare Corporation has completed the sale of six hospitals in California, which includes transactions involving four hospitals to UCI Health and two hospitals to Adventist Health. The completed sales align with prior disclosures and approvals from the University of California Board of Regents. This strategic move allows Tenet to focus on its core operations, as it continues to provide a wide range of healthcare services across its network. The sale represents a significant shift in Tenet's operational landscape in the state.
Read more →-THC
Feb 29, 2024Tenet to Sell Two Hospitals and Enter into a Revenue Cycle Services Partnership with Adventist Health Tenet announces agreement to sell San Luis Obispo County hospitals and related operations as well as a new health syst
Tenet Healthcare Corporation has announced an agreement to sell two hospitals in San Luis Obispo County to Adventist Health for roughly $550 million. This sale is expected to generate approximately $275 million in pre-tax book gain for Tenet. Additionally, Tenet's subsidiary, Conifer Health Solutions, will collaborate with Adventist Health to enhance revenue cycle management services. The transaction is anticipated to finalize in spring 2024, pending regulatory approvals.
Read more →-THC
Feb 16, 2024Tenet Calls for Full Redemption of 4.875% Senior Secured First Lien Notes due 2026 DALLAS
Tenet Healthcare Corporation announced the full redemption of its outstanding $2.1 billion of 4.875% Senior Secured First Lien Notes due 2026. The redemption is scheduled for March 5, 2024, and will be executed using cash on hand at a price equal to 100% of the principal along with accrued interest. This decision reflects Tenet's strategy to manage its financial obligations and enhance its fiscal stability as it continues to operate a diversified healthcare service network.
Read more →-THC
Feb 1, 2024▲ +7.7%on this news
Tenet Advances Portfolio Transformation and Previews Strong 2023 Results Tenet completes sale of three South Carolina hospitals and announces the sale of four Orange County and Los Angeles County hospitals and related op
Tenet Healthcare Corporation has completed the sale of three hospitals in South Carolina to Novant Health for about $2.4 billion and announced a deal to sell four hospitals in California for approximately $975 million. The transactions are expected to enhance cash flow and enable Tenet to lower its leverage. Additionally, the company indicated that its FY23 adjusted EBITDA will exceed previous guidance, reflecting robust performance in its surgical services segment. These strategic sales align with Tenet's ongoing portfolio transformation.
Read more →-THC
Feb 1, 2024▲ +7.7%on this news
TENET HEALTHCARE CORPORATION UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The following unaudited pro forma condensed consolidated financial statements are based on the Company's historical consolidate
Tenet Healthcare Corporation has released its unaudited pro forma condensed consolidated financial statements, reflecting adjustments from a recent transaction. The statements illustrate changes based on the company's historical results and include estimated adjustments for assets and liabilities. Management asserts that necessary adjustments for presentation fairness have been made. However, the nature of pro forma data indicates it may not accurately predict future financial impacts.
Read more →-THC
Jan 31, 2024Tenet Reports Fourth Quarter and FY 2023 Results Provides 2024 Financial Outlook Net income from continuing operations available to common shareholders in fourth quarter 2023 was $244 million, or $2.30 per diluted share
Tenet Healthcare Corporation reported strong financial results for the fourth quarter and full year 2023, with net income available to common shareholders rising to $244 million. The company achieved an Adjusted EBITDA of $1.012 billion, a 12.8% increase year-over-year, driven by effective operational management and growth in the Ambulatory Care segment. Tenet also provided a positive outlook for FY 2024, expecting Adjusted EBITDA to be between $3.285 billion and $3.485 billion as it pursues strategic sales of hospital assets.
Read more →-THC
Nov 17, 2023▲ +9.6%on this news
Tenet Healthcare to Sell Three South Carolina Hospitals to Novant Health Dallas, TX
Tenet Healthcare Corporation has finalized a deal to sell three hospitals in South Carolina to Novant Health for roughly $2.4 billion. The agreement includes various facilities, revenue cycle management services from Tenet's Conifer Health Solutions, and an expanded partnership with USPI for ambulatory services. The three involved hospitals generated significant revenue and are expected to improve community healthcare quality under Novant's management. The transaction is set to close in the first quarter of 2024, pending regulatory approvals.
Read more →-THC
Oct 30, 2023Tenet Reports Third Quarter 2023 Results Raises 2023 Outlook Net income from continuing operations available to common shareholders in third quarter 2023 was $101 million, or $0.94 per diluted share Adjusted diluted earn
Tenet Healthcare Corporation reported its Q3 2023 financial results, highlighting a net income of $101 million or $0.94 per diluted share. The company raised its Adjusted EBITDA outlook for the fiscal year 2023 to between $3.365 billion and $3.465 billion due to strong performance driven by revenue growth and cost controls. Notably, Ambulatory Care Adjusted EBITDA increased by 16% year-over-year, although overall net income was lower than the previous year's figures. Tenet continues to leverage growth in both the ambulatory and hospital segments despite some challenges in adjusted earnings statistics.
Read more →-THC
Jul 31, 2023Tenet Reports Second Quarter 2023 Results Raises 2023 Outlook Net income from continuing operations available to common shareholders in second quarter 2023 was $123 million, or $1.15 per diluted share Adjusted diluted ea
Tenet Healthcare Corporation reported a robust financial performance for the second quarter of 2023, with net income rising to $123 million compared to $38 million in the same quarter last year. The company saw a strong growth momentum in its ambulatory care segment, contributing to a 16.4% increase in Adjusted EBITDA. The outlook for fiscal year 2023 Adjusted EBITDA has been raised, reflecting positive operational trends. However, adjusted diluted earnings per share saw a slight decline, and the company also faced increased tax expenses during the quarter.
Read more →-THC
Jun 23, 2023Tenet Announces Chief Financial Officer Transition DALLAS
Tenet Healthcare Corporation has announced the appointment of Sun Park as the new Chief Financial Officer effective January 1, 2024, succeeding Dan Cancelmi who is retiring. Sun Park has a strong background in corporate and operational finance, having most recently served as Chief Financial Officer at AmerisourceBergen. His expertise is expected to benefit Tenet as it aims to continue its growth and value creation. The transition is part of the company’s planned leadership strategy, ensuring stability during this change.
Read more →-THC
May 2, 2023Tenet Announces $1.350 Billion Private Offering of Senior Secured Notes DALLAS
Tenet Healthcare Corporation announced a private placement offering of $1.350 billion in senior secured first lien notes maturing in 2031. The proceeds from this offering will be used to redeem outstanding higher-interest notes due in 2024. The new notes will be secured and guaranteed by certain subsidiaries of Tenet, which may reduce its overall debt burden. However, the offering is subject to pricing and customary closing conditions and is limited to qualified institutional buyers.
Read more →-THC
Apr 25, 2023Tenet Reports First Quarter 2023 Results Raises 2023 Outlook Net income from continuing operations available to common shareholders in first quarter 2023 was $143 million, or $1.32 per diluted share Adjusted diluted earn
Tenet Healthcare Corporation reported a positive start to 2023 with net income from continuing operations reaching $143 million, up from $139 million in Q1 2022. The company's adjusted EBITDA forecast for 2023 has been raised to between $3.210 billion and $3.410 billion, reflecting strong growth in its ambulatory care segment. However, adjusted diluted earnings per share fell to $1.42, and the hospital segment's adjusted EBITDA declined compared to the previous year. Overall, Tenet showcased growth in revenues and surgical cases, despite challenges in certain areas driven by lower COVID-related volumes.
Read more →-THC
Feb 9, 2023Tenet Reports Fourth Quarter and FY 2022 Results Provides 2023 Financial Outlook Net income from continuing operations available to common shareholders in fourth quarter 2022 was $102 million, or $0.92 per diluted share
Tenet Healthcare Corporation reported its financial results for the fourth quarter and full year of 2022, revealing a decrease in net income from continuing operations to $102 million, equating to $0.92 per diluted share. The adjusted EBITDA showed signs of growth in the Ambulatory Care segment, increasing 18.7% compared to the previous year. However, the company faced significant impairment charges and a notable decline in income compared to 2021. For 2023, Tenet projects an adjusted EBITDA between $3.160 billion and $3.360 billion as it focuses on expanding its ambulatory business and enhancing operational efficiencies.
Read more →-THC
Jan 19, 2023Tenet Anticipates Beating Midpoint of Latest 2022 Outlook Announces Key Leadership Updates DALLAS
Tenet Healthcare Corporation (THC) anticipates exceeding the midpoint of its FY22 Adjusted EBITDA guidance, reporting strong performance across its business units. The company has announced key leadership transitions, including the retirements of several executives and has initiated national searches for their successors. Tenet's strategic updates and leadership changes are designed to bolster long-term performance as it heads into 2023. Despite the optimistic outlook, uncertainties around the closure of financial processes were noted, alongside potential challenges during leadership transitions.
Read more →-THC
Oct 20, 2022Tenet Reports Third Quarter 2022 Results Announces $1 Billion Share Repurchase Program Net income from continuing operations available to common shareholders in third quarter 2022 was $131 million, or $1.16 per diluted s
Tenet Reports Third Quarter 2022 Results Announces $1 Billion Share Repurchase Program Net income from continuing operations available to common shareholders in third quarter 2022 was $131 million, or $1.16 per diluted share Adjusted diluted earnings per share from continuing
Read more →-THC
Jun 30, 2022▼ -7.1%on this news
Tenet Reports Second Quarter 2022 Results Reaffirms 2022 Adjusted EBITDA Outlook Net income from continuing operations available to common shareholders in Q2'22 of $38 million versus $120 million in Q2'21 Consolidated Ad
Tenet Reports Second Quarter 2022 Results Reaffirms 2022 Adjusted EBITDA Outlook Net income from continuing operations available to common shareholders in Q2'22 of $38 million versus $120 million in Q2'21 Consolidated Adjusted EBITDA in Q2'22 of $843 million versus $834 millio
Read more →-THC
Jun 1, 2022Tenet Announces $1.800 Billion Private Offering of Senior Secured Notes DALLAS
Tenet Announces $1.800 Billion Private Offering of Senior Secured Notes DALLAS June 1, 2022 Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.800 billion in aggregate principal amount of new senior secured first lien notes maturing in 2
Read more →-THC
Apr 20, 2022▲ +5.5%on this news
Tenet Reports First Quarter 2022 Results Retired over $800 Million of Debt To Date in 2022 Maintains 2022 Adjusted EBITDA Outlook Net income from continuing operations available to common shareholders in Q1'22 of $139 mi
Tenet Reports First Quarter 2022 Results Retired over $800 Million of Debt To Date in 2022 Maintains 2022 Adjusted EBITDA Outlook Net income from continuing operations available to common shareholders in Q1'22 of $139 million ($135 million excluding grant income) versus net in
Read more →-THC
Mar 17, 2022Tenet Announces Amendment to its Credit Agreement DALLAS
Tenet Announces Amendment to its Credit Agreement DALLAS March 17, 2022 Tenet Healthcare Corporation (NYSE: THC) today announced that it has entered into an amendment to its existing senior secured revolving credit facility. The amendment has an effective date of March 16, 2022
Read more →-THC
Mar 1, 2022Conifer to Remain Part of Tenet with Strong Path Forward Conference call scheduled for today, March 1, at 10 00 a.m. Eastern Time (9 00 Central Time) DALLAS
Conifer to Remain Part of Tenet with Strong Path Forward Conference call scheduled for today, March 1, at 10 00 a.m. Eastern Time (9 00 Central Time) DALLAS - March 1, 2022 - Tenet Healthcare Corporation (NYSE THC) announced today that - based on ongoing shareholder value creat
Read more →-THC
Feb 7, 2022Tenet Reports Strong Fourth Quarter and FY 2021 Results Announces Plan to Retire $700 Million of Debt Provides Detailed 2022 Financial Outlook Net income from continuing operations available to common shareholders in Q4'
Tenet Reports Strong Fourth Quarter and FY 2021 Results Announces Plan to Retire $700 Million of Debt Provides Detailed 2022 Financial Outlook Net income from continuing operations available to common shareholders in Q4'21 of $250 million ($153 million excluding grant income)
Read more →-THC
Dec 22, 2021Tenet and USPI Complete Transaction to Acquire
Tenet and USPI Complete Transaction to Acquire SCD DALLAS Dec. 22, 2021 Tenet Healthcare Corporation (NYSE: THC) and its subsidiary United Surgical Partners International (USPI) today completed their previously announced transaction to acquire SurgCenter Development (SCD). In c
Read more →-THC
Nov 16, 2021Tenet Announces $1.450 Billion Private Offering of Senior Secured Notes DALLAS Nov. 16 , 2021 Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.450 billion in aggregate principal
Tenet Announces $1.450 Billion Private Offering of Senior Secured Notes DALLAS Nov. 16, 2021 Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.450 billion in aggregate principal amount of newly issued senior secured first lien notes mat
Read more →-THC
Nov 8, 2021Tenet and USPI to Acquire SurgCenter Development and Establish Long-Term Development Partnership Acquiring ownership interests in 92 ambulatory surgery centers Includes formation of five-year partnership and development
Tenet and USPI to Acquire SurgCenter Development and Establish Long-Term Development Partnership Acquiring ownership interests in 92 ambulatory surgery centers Includes formation of five-year partnership and development agreement between USPI and SCD to provide continuity for S
Read more →-THC
Oct 20, 2021Tenet Reports Third Quarter 2021 Results Raises 2021 Financial Guidance Net income from continuing operations available to common shareholders in Q3'21 of $448 million versus a net loss from continuing operations of $197
Tenet Reports Third Quarter 2021 Results Raises 2021 Financial Guidance Net income from continuing operations available to common shareholders in Q3'21 of $448 million versus a net loss from continuing operations of $197 million in Q3'20 Consolidated Adjusted EBITDA in Q3'21 o
Read more →-THC
Aug 9, 2021Tenet Announces Leadership Transition Saum Sutaria appointed Chief Executive Officer; Ron Rittenmeyer remains Executive Chairman of Tenet DALLAS
Tenet Announces Leadership Transition Saum Sutaria appointed Chief Executive Officer; Ron Rittenmeyer remains Executive Chairman of Tenet DALLAS Aug. 9, 2021 Tenet Healthcare Corporation (NYSE: THC) today announced the next step in its long-term leadership succession plan. Ro
Read more →-THC
Aug 2, 2021Tenet Completes Sale of Five Hospitals in the Miami-Dade Southern Broward Area DALLAS
Tenet Completes Sale of Five Hospitals in the Miami-Dade Southern Broward Area DALLAS - August 2, 2021 - Tenet Healthcare Corporation (NYSE THC) today announced that it has completed the sale of its five hospitals and related operations in the Miami-Dade and Southern Broward co
Read more →-THC
Jul 21, 2021Tenet Reports Second Quarter 2021 Results Raises 2021 Financial Guidance Net income from continuing operations available to common shareholders in Q2'21 of $120 million versus net income from continuing operations of $88
Tenet Reports Second Quarter 2021 Results Raises 2021 Financial Guidance Net income from continuing operations available to common shareholders in Q2'21 of $120 million versus net income from continuing operations of $88 million in Q2'20 Consolidated Adjusted EBITDA in Q2'21 o
Read more →-THC
Jun 16, 2021STEWARD HEALTH CARE TO ACQUIRE FIVE HOSPITALS IN THE MIAMI-DADE SOUTHERN BROWARD AREA FROM TENET HEALTHCARE Acquisition of Tenet hospitals and hospital-affiliated operations will bring greater access to high-quality care
STEWARD HEALTH CARE TO ACQUIRE FIVE HOSPITALS IN THE MIAMI-DADE SOUTHERN BROWARD AREA FROM TENET HEALTHCARE Acquisition of Tenet hospitals and hospital-affiliated operations will bring greater access to high-quality care in South Florida DALLAS, TX (June 16, 2021) - Today, Stew
Read more →-THC
May 18, 2021Tenet Announces $1.4 Billion Private Offering of Senior Secured Notes DALLAS
Tenet Announces $1.4 Billion Private Offering of Senior Secured Notes DALLAS May 18, 2021 Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.4 billion in aggregate principal amount of newly issued senior secured first lien notes maturing
Read more →-THC
Apr 20, 2021Tenet Reports First Quarter 2021 Results Raises 2021 Financial Guidance Net income from continuing operations available to common shareholders in 1Q21 of $97 million versus net income from continuing operations of $94 mi
Tenet Reports First Quarter 2021 Results Raises 2021 Financial Guidance Net income from continuing operations available to common shareholders in 1Q21 of $97 million versus net income from continuing operations of $94 million in 1Q20 the 2020 quarter included a $91 million inco
Read more →-THC
Feb 9, 2021Tenet Reports Fourth Quarter 2020 Results Announces Plan to Retire $478 million of Debt Provides 2021 Financial Guidance Net income from continuing operations available to common shareholders in 4Q20 of $414 million vers
Tenet Reports Fourth Quarter 2020 Results Announces Plan to Retire $478 million of Debt Provides 2021 Financial Guidance Net income from continuing operations available to common shareholders in 4Q20 of $414 million versus a net loss from continuing operations of $3 million in
Read more →-THC
Dec 10, 2020Tenet to Acquire Portfolio of Surgery Centers from SurgCenter Development Expands USPI ambulatory business in line with Tenet s stated strategy Addition of up to 45 SCD centers cements Tenet s position as preeminent nati
Tenet to Acquire Portfolio of Surgery Centers from SurgCenter Development Expands USPI ambulatory business in line with Tenet s stated strategy Addition of up to 45 SCD centers cements Tenet s position as preeminent national musculoskeletal services leader across care Investme
Read more →-THC
Oct 20, 2020T enet Reports Third Quarter 2020 Results and Provides Update on Effects of COVID-19 Net loss from continuing operations attributable to common shareholders in 3Q20 of $197 million (which included an after-tax loss of $2
Tenet Reports Third Quarter 2020 Results and Provides Update on Effects of COVID-19 Net loss from continuing operations attributable to common shareholders in 3Q20 of $197 million (which included an after-tax loss of $237 million associated with early retirement of debt transac
Read more →-THC
Sep 1, 2020Tenet Announces $2.5 Billion Private Offering of Senior Notes DALLAS
Tenet Announces $2.5 Billion Private Offering of Senior Notes DALLAS September 1, 2020 Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $2.5 billion in aggregate principal amount of newly issued senior notes maturing in 2028 (the notes ).
Read more →-THC
Aug 3, 2020T enet Reports Results for the Second Quarter Ended
Tenet Reports Results for the Second Quarter Ended June 30, 2020 and Provides Update on Effects of COVID-19 Net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20 versus net income from continuing operations o
Read more →-THC
Jun 2, 2020Tenet Announces $600 Million Private Offering of Senior Secured Notes DALLAS
Tenet Announces $600 Million Private Offering of Senior Secured Notes DALLAS June 2, 2020 Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $600 million in aggregate principal amount of newly issued senior secured first lien notes maturing
Read more →-THC
May 4, 2020T enet Reports Results for the First Quarter Ended
Tenet Reports Results for the First Quarter Ended March 31, 2020 and Provides Update on Effects of COVID-19 DALLAS - May 4, 2020 - Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2020 (1Q20). "Our first quarter repr
Read more →-THC
Apr 2, 2020Tenet Announces $500 Million Private Offering of Senior Secured Notes DALLAS
Tenet Announces $500 Million Private Offering of Senior Secured Notes DALLAS - April 2, 2020 - Tenet Healthcare Corporation (NYSE: THC) announces a private placement offering of $500 million in aggregate principal amount of newly issued senior secured first lien notes maturing i
Read more →-THC
Apr 2, 2020Tenet Provides Business and Financial Update Related to COVID-19 DALLAS
Tenet Provides Business and Financial Update Related to COVID-19 DALLAS - April 2, 2020 - Tenet Healthcare Corporation (NYSE: THC) will provide a business update today regarding impacts related to the recent outbreak of the novel coronavirus (COVID-19). The presentation is sched
Read more →-THC
Feb 24, 2020T enet Reports Results for the Fourth Quarter and Year Ended
Tenet Reports Results for the Fourth Quarter and Year Ended December 31, 2019 and Issues Financial Outlook for 2020 DALLAS - February 24, 2020 - Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2019 (4Q19). "Our f
Read more →-THC
Dec 13, 2019Tenet Announces Definitive Agreement to Divest Memphis-Area Hospitals and Operations DALLAS
Tenet Announces Definitive Agreement to Divest Memphis-Area Hospitals and Operations DALLAS - Dec. 13, 2019 - Tenet Healthcare (NYSE: THC) has entered into a definitive agreement with Methodist Le Bonheur Healthcare to divest Tenet's hospitals and other operations in the Memphis
Read more →-THC
Nov 4, 2019Tenet Reports Results for the Third Quarter Ended
Tenet Reports Results for the Third Quarter Ended September 30, 2019 DALLAS - Nov. 4, 2019 - Tenet Healthcare Corporation (NYSE: THC) today announced its results for the third quarter ended September 30, 2019. Ronald A. Rittenmeyer, Executive Chairman and CEO, said, "We had a v
Read more →-THC
Aug 19, 2019Tenet Appoints Nadja West, M.D., as New Independent Director Surgeon General of the U.S. Army and Former Commanding General of the U.S. Army Medical Command Brings Significant Healthcare Leadership Experience Ed Kangas a
Tenet Appoints Nadja West, M.D., as New Independent Director Surgeon General of the U.S. Army and Former Commanding General of the U.S. Army Medical Command Brings Significant Healthcare Leadership Experience Ed Kangas and Brenda Gaines to Retire from the Board in November as P
Read more →-THC
Aug 12, 2019Tenet Announces Pricing of its Private Offering of Senior Secured Notes to Refinance $4.2 Billion in Outstanding Notes DALLAS
Tenet Announces Pricing of its Private Offering of Senior Secured Notes to Refinance $4.2 Billion in Outstanding Notes DALLAS August 12, 2019 Tenet Healthcare Corporation (NYSE: THC) established today the pricing of the previously announced private placement offering of $4.2 b
Read more →-THC
Aug 12, 2019Tenet Announces Private Offering of Senior Secured Notes to Refinance $4.2 Billion in Outstanding Notes DALLAS
Tenet Announces Private Offering of Senior Secured Notes to Refinance $4.2 Billion in Outstanding Notes DALLAS August 12, 2019 Tenet Healthcare Corporation (NYSE: THC) intends to refinance up to $4.2 billion of its currently outstanding notes by a private placement offering of
Read more →-THC
Aug 5, 2019Tenet Reports Results for the Second Quarter Ended
Tenet Reports Results for the Second Quarter Ended June 30, 2019 DALLAS - Aug. 5, 2019 - Tenet Healthcare Corporation (NYSE: THC) reported net income from continuing operations attributable to Tenet common shareholders of $15 million in the second quarter of 2019 compared to net
Read more →-THC
Jul 24, 2019Tenet Concludes Conifer Strategic Review Process and Plans to Complete a Tax-Free Spin-Off of the Business by the end of the Second Quarter of 2021 Company Reaffirms Adjusted EBITDA Outlook for the Second Quarter and Ful
Tenet Concludes Conifer Strategic Review Process and Plans to Complete a Tax-Free Spin-Off of the Business by the end of the Second Quarter of 2021 Company Reaffirms Adjusted EBITDA Outlook for the Second Quarter and Full Year 2019 Tenet Announces CEO Transition at Conifer DA
Read more →-THC
Apr 29, 2019Tenet Reports Results for the First Quarter Ended
Tenet Reports Results for the First Quarter Ended March 31, 2019 DALLAS - April 29, 2019 - Tenet Healthcare Corporation (NYSE: THC) reported a net loss from continuing operations attributable to Tenet common shareholders of $27 million in the first quarter of 2019 compared to ne
Read more →-THC
Feb 25, 2019Tenet Reports Results for the Fourth Quarter and Year Ended
Tenet Reports Results for the Fourth Quarter and Year Ended December 31, 2018 and Issues Outlook for 2019 DALLAS - February 25, 2019 - Tenet Healthcare Corporation (NYSE: THC) reported net income from continuing operations attributable to Tenet common shareholders of $108 millio
Read more →-THC
Jan 29, 2019Unaudited Pro Forma Financial Statements The following Unaudited Pro Forma Financial Statements are based on the Company's historical consolidated results of operations and financial position, adjusted to give effect to
Unaudited Pro Forma Financial Statements The following Unaudited Pro Forma Financial Statements are based on the Company's historical consolidated results of operations and financial position, adjusted to give effect to the Transaction, as defined in Item 2.01 of this Form 8-K,
Read more →-THC
May 29, 2018Tenet Board Appoints Two Independent Directors DALLAS
Tenet Board Appoints Two Independent Directors DALLAS - May 29, 2018 - Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of two independent directors to its Board: General Lloyd J. Austin, III and Meghan M. FitzGerald, DrPH. Bob Kerrey, Lead Director, sai
Read more →-THC
Mar 26, 2018Tenet Reaches Agreement with Glenview Implements Additional Governance Enhancements DALLAS
Tenet Reaches Agreement with Glenview Implements Additional Governance Enhancements DALLAS March 26, 2018 Tenet Healthcare Corporation (NYSE: THC) today announced that its Board of Directors has reached an agreement with Glenview Capital Management ( Glenview ) under which Gle
Read more →-THC
Mar 5, 2018Tenet Announces Governance Enhancements DALLAS
Tenet Announces Governance Enhancements DALLAS March 5, 2018 Tenet Healthcare Corporation (NYSE: THC) today announced that its Board of Directors has taken a series of actions to strengthen the Company s corporate governance. The initiatives follow the Board s ongoing review of
Read more →-THC
Feb 26, 2018Tenet Reports Results for the Fourth Quarter Ended
Tenet Reports Results for the Fourth Quarter Ended DALLAS - February 26, 2018 - Tenet Healthcare Corporation (NYSE: THC) reported a net loss from continuing operations attributable to Tenet shareholders of $230 million in the fourth quarter of 2017 due to the items mentioned abo
Read more →-THC
Jan 11, 2018Tenet Completes Sale of Philadelphia-Area Hospitals and Related Operations DALLAS
Tenet Completes Sale of Philadelphia-Area Hospitals and Related Operations DALLAS - January 11, 2018 - Tenet Healthcare Corporation (NYSE: THC) announced today that it has completed the sale of its Philadelphia-area acute care hospitals and related operations to American Academ
Read more →-THC
Dec 19, 2017Tenet Announces Process to Explore a Potential Sale of Conifer, Provides Updates on Cost Reduction and Board Refreshment Initiatives, and Issues Outlook for 2018 l Targeted cost reduction program has been expanded and is
Tenet Announces Process to Explore a Potential Sale of Conifer, Provides Updates on Cost Reduction and Board Refreshment Initiatives, and Issues Outlook for 2018 DALLAS - December 19, 2017 - Tenet Healthcare Corporation (NYSE: THC) today announced additional actions to support t
Read more →-THC
Oct 27, 2017Tenet Releases Preliminary Results for the Third Quarter of 2017, Announces $150 Million Cost Reduction Initiative and Appoints New Independent Director
Tenet Releases Preliminary Results for the Third Quarter of 2017, Announces $150 Million Cost Reduction Initiative and Appoints New Independent Director Net loss from continuing operations attributable to Tenet shareholders is expected to be approximately $366 million Adjusted
Read more →-THC
Oct 23, 2017Tenet CEO Trevor Fetter Departs Company As Part of Previously Announced Leadership Transition DALLAS
Tenet CEO Trevor Fetter Departs Company As Part of Previously Announced Leadership Transition DALLAS October 23, 2017 Tenet Healthcare Corporation (NYSE: THC) (the Company ) today announced that Trevor Fetter has stepped down from his role as chief executive officer and resign
Read more →-THC
Sep 1, 2017Tenet and Paladin Healthcare Reach Definitive Agreement to Transfer Ownership of Tenet s Philadelphia Hospitals Sale Agreement Includes Hahnemann University Hospital, St. Christopher s Hospital for Children
Tenet and Paladin Healthcare Reach Definitive Agreement to Transfer Ownership of Tenet s Philadelphia Hospitals Sale Agreement Includes Hahnemann University Hospital, St. Christopher s Hospital for Children and Related Operations Philadelphia, PA September 1, 2017 Tenet Healthc
Read more →-THC
Aug 31, 2017Tenet Announces CEO Transition, Commencement of Board Refreshment Process, and Implementation of Shareholder Rights Plan to Protect NOLs Tenet chairman and chief executive officer Trevor Fetter to step down following a t
Tenet Announces CEO Transition, Commencement of Board Refreshment Process, and Implementation of Shareholder Rights Plan to Protect NOLs DALLAS August 31, 2017 Tenet Healthcare Corporation (NYSE: THC) (the Company ) today announced that Chairman and CEO Trevor Fetter will step
Read more →-THC
Aug 1, 2017Tenet Completes Sale of Houston-Area Acute Care Hospitals and Related Operations to
Tenet Completes Sale of Houston-Area Acute Care Hospitals and Related Operations to HCA DALLAS - August 1, 2017 - Tenet Healthcare Corporation (NYSE:THC) announced today that it has completed the sale of its Houston-area acute care hospitals and related operations to HCA Healthc
Read more →-THC
Jun 5, 2017Tenet Announces Pricing of its Private Offering of Senior Secured and Unsecured Notes to Refinance $3.541 Billion in Outstanding Notes DALLAS
Tenet Announces Pricing of its Private Offering of Senior Secured and Unsecured Notes to Refinance $3.541 Billion in 5, 2017 Tenet Healthcare Corporation (NYSE: THC) established today the pricing of the previously announced private offering of newly issued notes to refinance $3
Read more →-THC
Jun 5, 2017Tenet Announces Private Offering of Senior Secured and Unsecured Notes to Refinance $3.541 Billion in Outstanding Notes DALLAS
Tenet Announces Private Offering of Senior Secured and Unsecured Notes to Refinance $3.541 Billion in Outstanding Notes DALLAS June 5, 2017 Tenet Healthcare Corporation (NYSE: THC) intends to refinance $3.541 billion of its currently outstanding notes by offering to sell $3.78
Read more →-THC
Dec 1, 2016Tenet Announces Completion of its Private Offering of Senior Secured Second Lien Notes DALLAS
Tenet Announces Completion of its Private Offering of Senior Secured Second Lien Notes DALLAS December 1, 2016 Tenet Healthcare Corporation (NYSE: THC) has completed its previously announced private offering of $750 million aggregate principal amount of senior secured second l
Read more →-THC
Nov 16, 2016Tenet Announces Upsizing and Pricing of its Private Offering of Senior Secured Second Lien Notes DALLAS
Tenet Announces Upsizing and Pricing of its Private Offering of Senior Secured Second Lien Notes DALLAS November 16, 2016 Tenet Healthcare Corporation (NYSE: THC) established today the pricing of the previously announced private offering of senior secured second lien notes mat
Read more →-THC
Nov 16, 2016Tenet Announces Private Offering of Senior Secured Second Lien Notes DALLAS
Tenet Announces Private Offering of Senior Secured Second Lien Notes DALLAS November 16, 2016 Tenet Healthcare Corporation (NYSE: THC) is offering to sell $500 million aggregate principal amount of newly issued senior secured second lien notes (the notes ) through a private pl
Read more →-THC
Nov 4, 2016Tenet Healthcare Board Appoints Two New Independent Directors New Directors Bring Significant Healthcare, Finance and Public Company Experience DALLAS
Tenet Healthcare Board Appoints Two New Independent Directors New Directors Bring Significant Healthcare, Finance and Public Company Experience November 4, 2016 The board of directors of Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of two new indepe
Read more →-THC
Oct 3, 2016Tenet Healthcare Finalizes Previously Disclosed Agreement to Resolve Clinica de la Mama Investigation and Litigation DALLAS
Tenet Healthcare Finalizes Previously Disclosed Agreement to Resolve Clinica de la Mama Investigation and Litigation DALLAS October 3, 2016 Tenet Healthcare Corporation (NYSE: THC) today announced that it has finalized its previously disclosed agreement in principle with the U
Read more →-THC
Apr 1, 2016Tenet Completes Sale of Atlanta-area Hospitals and Related Operations to WellStar DALLAS
Tenet Completes Sale of Atlanta-area Hospitals and Related Operations to WellStar DALLAS April 1, 2016 Tenet Healthcare Corporation (NYSE:THC) has completed the sale of its five Atlanta-area hospitals and related operations to WellStar Health System in exchange for $575 millio
Read more →-THC
Mar 22, 2016Tenet Appoints Eric Evans President of Hospital Operations DALLAS
Tenet Appoints Eric Evans President of Hospital Operations DALLAS March 22, 2016 Tenet Healthcare Corporation (NYSE: THC) today announced that Eric Evans, chief executive officer of the company s Texas Region, has been appointed president of Hospital Operations, effective immed
Read more →-THC
Jan 19, 2016Tenet Board Adds Two New Independent Directors Addition of Randy Simpson and Matt Ripperger from Glenview Capital Expands Board to 12 Members DALLAS
Tenet Board Adds Two New Independent Directors Addition of Randy Simpson and Matt Ripperger from Glenview Capital Expands Board to 12 Members DALLAS January 19, 2016 The board of directors of Tenet Healthcare Corporation (NYSE: THC) has appointed Randolph C. Simpson and Matthe
Read more →-THC
Dec 1, 2015Tenet and WellStar Reach Definitive Agreement for Sale of Tenet s Atlanta-area Hospitals and Related Operations DALLAS
Tenet and WellStar Reach Definitive Agreement for Sale of Tenet s Atlanta-area Hospitals and Related Operations DALLAS December 1, 2015 Tenet Healthcare Corporation (NYSE:THC) and WellStar Health System have entered into a definitive agreement for the sale and management of Te
Read more →-THC
Oct 23, 2015Tenet Reaffirms Adjusted EBITDA Outlook for the Third Quarter Ended
Tenet Reaffirms Adjusted EBITDA Outlook for the Third Quarter Ended September 30, 2015 DALLAS October 22, 2015 In light of the extraordinary volatility of its shares in recent days, Tenet Healthcare Corporation (NYSE:THC) is reaffirming its previously announced Adjusted EBITDA
Read more →-THC
Jun 16, 2015Tenet Healthcare Corporation Completes United Surgical Partners International and Aspen Healthcare Transactions DALLAS
Tenet Healthcare Corporation Completes United Surgical Partners International and Aspen Healthcare Transactions DALLAS June 16, 2015 Tenet Healthcare Corporation (NYSE: THC) ( Tenet ) has completed its previously announced joint venture transaction with Welsh, Carson, Anderson
Read more →-THC
Jun 2, 2015Tenet Announces Upsizing and Pricing of Private Offering of Senior Secured Notes and Pricing of Senior Unsecured Notes DALLAS
Tenet Announces Upsizing and Pricing of Private Offering of Senior Secured Notes and Pricing of Senior Unsecured Notes DALLAS June 2, 2015 Tenet Healthcare Corporation (NYSE: THC) established today the pricing of the previously announced private offering of its floating rate s
Read more →-THC
Jun 2, 2015Tenet Announces Private Offering of Senior Secured and Unsecured Notes DALLAS
Tenet Announces Private Offering of Senior Secured and Unsecured Notes DALLAS June 2, 2015 Tenet Healthcare Corporation (NYSE: THC) is offering to sell $500 million aggregate principal amount of newly issued senior secured notes (the Tenet secured notes ) through a private pla
Read more →-THC
May 4, 2015Tenet Reports Adjusted EBITDA of $529 Million for the Quarter Ended
Tenet Reports Adjusted EBITDA of $529 Million for the Quarter Ended March 31, 2015 DALLAS May 4, 2015 Tenet Healthcare Corporation (NYSE:THC) reported Adjusted EBITDA of $529 million for the first quarter of 2015, an increase of $142 million, or 37 percent, compared to $387 mi
Read more →-THC
Mar 23, 2015BAYLOR SCOTT & WHITE HEALTH AND TENET TO PARTNER ON FIVE NORTH TEXAS HOSPITALS Partnership will extend coordinated and integrated care, advancing population health model DALLAS
BAYLOR SCOTT & WHITE HEALTH AND TENET TO PARTNER ON FIVE NORTH TEXAS HOSPITALS Partnership will extend coordinated and integrated care, advancing population health model DALLAS March 23, 2015 Baylor Scott & White Health and Tenet Healthcare Corporation (NYSE: THC) today announ
Read more →-THC
Mar 23, 2015Tenet, United Surgical Partners International and Welsh Carson to Create the Nation s Largest Ambulatory Surgery Platform Tenet and USPI to Combine Their Ambulatory Surgery and Imaging Centers in New Joint V
Tenet, United Surgical Partners International and Welsh Carson to Create the Nation s Largest Ambulatory Surgery Platform Tenet and USPI to Combine Their Ambulatory Surgery and Imaging Centers in New Joint Venture Tenet to Own 50.1% with Path to Full Ownership Tenet Also Acqu
Read more →-THC
Mar 12, 2015Tenet Healthcare Names Tammy Romo to Board of Directors DALLAS
Tenet Healthcare Names Tammy Romo to Board of Directors DALLAS March 12, 2015 The board of directors of Tenet Healthcare Corporation (NYSE:THC) has appointed Tammy Romo, senior vice president of finance and chief financial officer of Southwest Airlines Co., as a new independent
Read more →-THC
Feb 23, 2015Tenet Reports Adjusted EBITDA of $646 Million for the Quarter Ended
Tenet Reports Adjusted EBITDA of $646 Million for the Quarter Ended December 31, 2014 DALLAS February 23, 2015 Tenet Healthcare Corporation (NYSE:THC) reported Adjusted EBITDA of $646 million for the fourth quarter ended December 31, 2014, an increase of $202 million, or 45.5
Read more →-THC
Dec 31, 2014Tenet Releases 2015 Outlook Previews 2014 Results Strong Volume Growth Sustained in Quarter Ended
Tenet Releases 2015 Outlook Previews 2014 Results Strong Volume Growth Sustained in Quarter Ended Dec. 31, 2014 DALLAS January 12, 2015 Tenet Healthcare Corporation (NYSE:THC) released its Outlook for 2015. The company expects its Adjusted EBITDA for 2015 to be in a range of
Read more →-THC
Dec 4, 2014Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors DALLAS
Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors DALLAS December 4, 2014 The board of directors of Tenet Healthcare Corporation (NYSE:THC) has appointed Freda C. Lewis-Hall, M.D., executive vice president and chief medical officer of Pfizer Inc., as a new in
Read more →-THC
Nov 3, 2014Tenet Reports Adjusted EBITDA of $459 Million for the Quarter Ended
Tenet Reports Adjusted EBITDA of $459 Million for the Quarter Ended September 30, 2014 Raises 2014 Adjusted EBITDA Outlook to $1.90 to $1.95 Billion DALLAS November 3, 2014 Tenet Healthcare Corporation (NYSE:THC) reported Adjusted EBITDA for the third quarter ended September 3
Read more →-THC
Sep 24, 2014Tenet Announces Private Offering of Senior Notes DALLAS
Tenet Announces Private Offering of DALLAS September 24, 2014 Tenet Healthcare Corporation (NYSE: THC) is offering to sell $500 million aggregate principal amount of senior notes through a private placement. The proceeds from the offering will be used for general corporate purpo
Read more →Competitive Position
How THC ranks across every disease it competes inCompetitive Position is a premium feature
See how THC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial